Serum Cytokines as Biomarkers in Heart Failure with Preserved Ejection Fraction and Sleep Apnea: A Prospective Cohort Study

Heart failure with preserved ejection fraction (HFpEF) and obstructive sleep apnea (OSA) frequently co-occur and this comorbidity represents a separate phenotype of HFpEF. While many research attempts are focused on biomarkers of HFpEF, currently, there is a lack of validated biomarkers of HFpEF and...

Full description

Bibliographic Details
Main Authors: Alexey Yakovlev, Alexander Teplyakov, Elena Grakova, Sergey Shilov, Natalia Yakovleva, Kristina Kopeva, Valery Shirinsky, Ivan Shirinsky
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/13/3/628
_version_ 1797610653269098496
author Alexey Yakovlev
Alexander Teplyakov
Elena Grakova
Sergey Shilov
Natalia Yakovleva
Kristina Kopeva
Valery Shirinsky
Ivan Shirinsky
author_facet Alexey Yakovlev
Alexander Teplyakov
Elena Grakova
Sergey Shilov
Natalia Yakovleva
Kristina Kopeva
Valery Shirinsky
Ivan Shirinsky
author_sort Alexey Yakovlev
collection DOAJ
description Heart failure with preserved ejection fraction (HFpEF) and obstructive sleep apnea (OSA) frequently co-occur and this comorbidity represents a separate phenotype of HFpEF. While many research attempts are focused on biomarkers of HFpEF, currently, there is a lack of validated biomarkers of HFpEF and OSA. In this study, we aimed to evaluate prognostic significance of several serum cytokines in patients with HFpEF and OSA. The patients with HFpEF and OSA were recruited from the Sleep Apnea Center of Novosibirsk, Russian Federation and followed up for 12 months. The main analyzed outcomes were five-point major adverse cardiovascular events (MACE) and the 6-min walk test (6MWT). The analyzed cytokines were circulating IL-6, IL-10, and VEGF measured at baseline. We recruited 77 male patients with HFpEF and OSA, the data of 71 patients were available for analyses. Patients who developed MACE had four-fold elevated concentrations of serum IL-10. There was no association between baseline cytokine levels and longitudinal changes in 6MWT. Circulating IL-10 levels are positively associated with MACE in men with HFpEF and OSA and thus may be a potential prognostic biomarker in this subgroup of patients. These results should be confirmed in larger studies encompassing both males and females.
first_indexed 2024-03-11T06:17:16Z
format Article
id doaj.art-6ae5014228d14bdd961046289eee6f7c
institution Directory Open Access Journal
issn 2075-1729
language English
last_indexed 2024-03-11T06:17:16Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Life
spelling doaj.art-6ae5014228d14bdd961046289eee6f7c2023-11-17T12:10:09ZengMDPI AGLife2075-17292023-02-0113362810.3390/life13030628Serum Cytokines as Biomarkers in Heart Failure with Preserved Ejection Fraction and Sleep Apnea: A Prospective Cohort StudyAlexey Yakovlev0Alexander Teplyakov1Elena Grakova2Sergey Shilov3Natalia Yakovleva4Kristina Kopeva5Valery Shirinsky6Ivan Shirinsky7Department of Therapy, Hematology and Transfusiology, Novosibirsk State Medical University, Krasny Prospect, 52, 630091 Novosibirsk, RussiaCardiology Research Institute, Tomsk National Research Medical Center (NRMC), Kievskaya Str., 111a, 634012 Tomsk, RussiaDepartment of Myocardial Pathology, Cardiology Research Institute, Tomsk National Research Medical Center (NRMC), Kievskaya Str., 111a, 634012 Tomsk, RussiaDepartment of Pathological Physiology and Clinical Pathophysiology, Novosibirsk State Medical University, Krasny Prospect, 52, 630091 Novosibirsk, RussiaDepartment of Policlinic Therapy and General Medical Practice, Novosibirsk State Medical University, Krasny Prospect, 52, 630091 Novosibirsk, RussiaDepartment of Myocardial Pathology, Cardiology Research Institute, Tomsk National Research Medical Center (NRMC), Kievskaya Str., 111a, 634012 Tomsk, RussiaLaboratory of Clinical Immunopharmacology, Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology, 6 Zalesskogo Str., 630099 Novosibirsk, RussiaLaboratory of Clinical Immunopharmacology, Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology, 6 Zalesskogo Str., 630099 Novosibirsk, RussiaHeart failure with preserved ejection fraction (HFpEF) and obstructive sleep apnea (OSA) frequently co-occur and this comorbidity represents a separate phenotype of HFpEF. While many research attempts are focused on biomarkers of HFpEF, currently, there is a lack of validated biomarkers of HFpEF and OSA. In this study, we aimed to evaluate prognostic significance of several serum cytokines in patients with HFpEF and OSA. The patients with HFpEF and OSA were recruited from the Sleep Apnea Center of Novosibirsk, Russian Federation and followed up for 12 months. The main analyzed outcomes were five-point major adverse cardiovascular events (MACE) and the 6-min walk test (6MWT). The analyzed cytokines were circulating IL-6, IL-10, and VEGF measured at baseline. We recruited 77 male patients with HFpEF and OSA, the data of 71 patients were available for analyses. Patients who developed MACE had four-fold elevated concentrations of serum IL-10. There was no association between baseline cytokine levels and longitudinal changes in 6MWT. Circulating IL-10 levels are positively associated with MACE in men with HFpEF and OSA and thus may be a potential prognostic biomarker in this subgroup of patients. These results should be confirmed in larger studies encompassing both males and females.https://www.mdpi.com/2075-1729/13/3/628heart failurecytokinesprognosissleep apneaobstructivebiomarkers
spellingShingle Alexey Yakovlev
Alexander Teplyakov
Elena Grakova
Sergey Shilov
Natalia Yakovleva
Kristina Kopeva
Valery Shirinsky
Ivan Shirinsky
Serum Cytokines as Biomarkers in Heart Failure with Preserved Ejection Fraction and Sleep Apnea: A Prospective Cohort Study
Life
heart failure
cytokines
prognosis
sleep apnea
obstructive
biomarkers
title Serum Cytokines as Biomarkers in Heart Failure with Preserved Ejection Fraction and Sleep Apnea: A Prospective Cohort Study
title_full Serum Cytokines as Biomarkers in Heart Failure with Preserved Ejection Fraction and Sleep Apnea: A Prospective Cohort Study
title_fullStr Serum Cytokines as Biomarkers in Heart Failure with Preserved Ejection Fraction and Sleep Apnea: A Prospective Cohort Study
title_full_unstemmed Serum Cytokines as Biomarkers in Heart Failure with Preserved Ejection Fraction and Sleep Apnea: A Prospective Cohort Study
title_short Serum Cytokines as Biomarkers in Heart Failure with Preserved Ejection Fraction and Sleep Apnea: A Prospective Cohort Study
title_sort serum cytokines as biomarkers in heart failure with preserved ejection fraction and sleep apnea a prospective cohort study
topic heart failure
cytokines
prognosis
sleep apnea
obstructive
biomarkers
url https://www.mdpi.com/2075-1729/13/3/628
work_keys_str_mv AT alexeyyakovlev serumcytokinesasbiomarkersinheartfailurewithpreservedejectionfractionandsleepapneaaprospectivecohortstudy
AT alexanderteplyakov serumcytokinesasbiomarkersinheartfailurewithpreservedejectionfractionandsleepapneaaprospectivecohortstudy
AT elenagrakova serumcytokinesasbiomarkersinheartfailurewithpreservedejectionfractionandsleepapneaaprospectivecohortstudy
AT sergeyshilov serumcytokinesasbiomarkersinheartfailurewithpreservedejectionfractionandsleepapneaaprospectivecohortstudy
AT nataliayakovleva serumcytokinesasbiomarkersinheartfailurewithpreservedejectionfractionandsleepapneaaprospectivecohortstudy
AT kristinakopeva serumcytokinesasbiomarkersinheartfailurewithpreservedejectionfractionandsleepapneaaprospectivecohortstudy
AT valeryshirinsky serumcytokinesasbiomarkersinheartfailurewithpreservedejectionfractionandsleepapneaaprospectivecohortstudy
AT ivanshirinsky serumcytokinesasbiomarkersinheartfailurewithpreservedejectionfractionandsleepapneaaprospectivecohortstudy